Related Experiment Video
Updated: Jul 7, 2026

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
Prion diseases: from protein to cell pathology.
Gabor G Kovacs1, Herbert Budka
1Institute of Neurology, Medical University of Vienna, AKH 4J, Waehringer Guertel 18-20, POB 48, 1097 Vienna, Austria.
Prion diseases, fatal neurodegenerative conditions, involve prion protein (PrP) misfolding. This review analyzes pathways causing tissue damage, highlighting the complex neuropathogenesis and need for further research.
Area of Science:
- Neuroscience
- Pathology
- Infectious Diseases
Background:
- Prion diseases, or transmissible spongiform encephalopathies, are fatal neurodegenerative conditions affecting humans and animals.
- Pathogenesis involves the misfolding of cellular prion protein (PrP c) into a disease-associated form (PrP TSE), forming the infectious agent.
- Neuronal damage is central to prion disease manifestation but its mechanisms are not fully understood.
Purpose of the Study:
- To review and analyze the major pathogenetic pathways leading to tissue pathology in various forms of prion diseases.
- To elucidate the complex neuropathogenesis of prion diseases, comparing them to other neurodegenerative and infectious diseases.
- To investigate the roles of intracellular and extracellular prion protein accumulation in cellular dysfunction and tissue damage.
Main Methods:
- Literature review and analysis of existing research on prion disease pathogenesis.
- Examination of neuropathological findings across different prion disease models and human cases.
- Comparative analysis of pathogenetic pathways in prion diseases versus other neurodegenerative and infectious conditions.
Main Results:
- Neuropathogenesis of prion diseases involves multiple, interacting pathways, some shared with other neurodegenerative and infectious diseases.
- Intracellular accumulation of misfolded prion protein forms can impair cell function and cause cytopathology.
- Extracellular deposition of PrP TSE alone is unlikely to be a direct cytotoxic factor; tissue damage results from complex, parallel, or sequential pathways.
Conclusions:
- Prion disease neuropathogenesis is complex, involving multiple interacting pathways.
- Further research is needed to clarify the triggers, sequence, and dominant factors driving these pathogenetic processes.
- Understanding these pathways is crucial for developing effective therapeutic strategies against prion diseases.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Subviral Agents
Parkinson Disease ll: Pathophysiology
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA molecules by RNA...
Proteins: From Genes to Degradation
Transcription is the synthesis of RNA molecules by RNA...

